Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

DAWN holding history

Day One Biopharmaceuticals, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q2 2021
Holdings of DAWN by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,954,735−100.0%Sold outHolders
Q1 20261,954,735$41.9M<0.1%+76,897+4.1%AddedHolders
Q4 20251,877,838$17.5M<0.1%+116,574+6.6%AddedHolders
Q3 20251,761,264$12.4M<0.1%+48,835+2.9%AddedHolders
Q2 20251,712,429$11.1M<0.1%+171,964+11.2%AddedHolders
Q1 20251,540,465$12.2M<0.1%+77,483+5.3%AddedHolders
Q4 20241,462,982$18.5M<0.1%+30,285+2.1%AddedHolders
Q3 20241,432,697$20.0M<0.1%+136,458+10.5%AddedHolders
Q2 20241,296,239$17.9M<0.1%−80,722−5.9%ReducedHolders
Q1 20241,376,961$22.8M<0.1%+28,142+2.1%AddedHolders
Q4 20231,348,819$19.7M<0.1%+55,705+4.3%AddedHolders
Q3 20231,293,114$15.9M<0.1%+367,898+39.8%AddedHolders
Q2 2023925,216$11.0M<0.1%+336,740+57.2%AddedHolders
Q1 2023588,476$7.87M<0.1%+7,992+1.4%AddedHolders
Q4 2022580,484$12.5M<0.1%+25,854+4.7%AddedHolders
Q3 2022554,630$11.1M<0.1%+112,271+25.4%AddedHolders
Q2 2022442,359$7.92M<0.1%+119,664+37.1%AddedHolders
Q1 2022322,695$3.20M<0.1%+113,352+54.1%AddedHolders
Q4 2021209,343$3.53M<0.1%+22,716+12.2%AddedHolders
Q3 2021186,627$4.43M<0.1%+151,692+434.2%AddedHolders
Q2 202134,935$795.0K<0.1%+34,935NewHolders